Last 12 months
Inside the activity.
0 purchase rows · 96 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 18 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 16 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2019 Filed Feb 8, 2019 16:15 UTC |
Quinn Anthony G.Director · President & CEO
|
Exercise / conversionCommon Stock | 1,323 | $5.46 | $7,223.58 |
DisclosureSEC source: 0001567619-19-002796 · doc1.xml · nonDerivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2018 Filed Feb 14, 2022 17:19 UTC |
Quinn Anthony G.Director · President & CEO
|
GiftCommon Stock | 57,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 2 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 57,450 F1 · ownership.nature: These securities are held by the Anthony G. Quinn Irrevocable Trust of 2018, of which the Reporting Person's spouse is trustee. Read SEC document |
| December 28, 2018 Filed Feb 14, 2022 17:19 UTC |
Quinn Anthony G.Director · President & CEO
|
GiftCommon Stock | 57,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009407 · doc5.xml · nonDerivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,795 Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 18,584 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · derivative · entry 8 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,950 Underlying: Common Stock · 18,584 shares Expires 2028-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,306 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · derivative · entry 7 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,985 Underlying: Common Stock · 3,306 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vested and became exercisable as to 1/36th of the shares subject to the option on April 3, 2016, and thereafter vests as to 1/36th of the shares each month in equal installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · derivative · entry 6 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2027-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 100% of the shares subject to the option on July 18, 2018, subject to the continuing service of the Reporting Person on the vesting date. Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
Exercise / conversionCommon Stock | 18,584 | $6.31 | $117,265.04 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · nonDerivative · entry 5 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
Exercise / conversionCommon Stock | 3,306 | $5.46 | $18,050.76 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · nonDerivative · entry 4 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
Exercise / conversionCommon Stock | 150,000 | $4.11 | $616,500.00 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · nonDerivative · entry 3 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 17:11 UTC |
Schuchart AaronChief Business Officer
|
SaleCommon Stock | 5,900 | $9.50 | $56,050.00 |
DisclosureSEC source: 0001567619-18-003282 · doc1.xml · nonDerivative · entry 2 Schuchart Aaron · CIK 0001709258 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 17:11 UTC |
Schuchart AaronChief Business Officer
|
SaleCommon Stock | 100 | $9.55 | $955.00 |
DisclosureSEC source: 0001567619-18-003282 · doc1.xml · nonDerivative · entry 1 Schuchart Aaron · CIK 0001709258 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,400 Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 16:24 UTC |
Schuchart AaronChief Business Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,500 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001567619-18-001566 · doc1.xml · derivative · entry 2 Schuchart Aaron · CIK 0001709258 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,500 Underlying: Common Stock · 8,500 shares Expires 2027-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vested and became exercisable as to 1/4th of the shares subject to the option on May 22, 2018, and thereafter vests and becomes exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 16:24 UTC |
Schuchart AaronChief Business Officer
|
Exercise / conversionCommon Stock | 8,500 | $3.50 | $29,750.00 |
DisclosureSEC source: 0001567619-18-001566 · doc1.xml · nonDerivative · entry 1 Schuchart Aaron · CIK 0001709258 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
PurchaseCommon Stock | 994 | $9.13 | $9,075.22 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · nonDerivative · entry 2 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,787 F1 · shares: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 16:40 UTC |
GEORGIOU GEORGEDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001567619-18-001186 · doc1.xml · derivative · entry 4 GEORGIOU GEORGE · CIK 0000749811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 20,000 shares Expires 2027-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable, and shall continue to vest and become exercisable, in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 16:40 UTC |
GEORGIOU GEORGEDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 17,333 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001567619-18-001186 · doc1.xml · derivative · entry 3 GEORGIOU GEORGE · CIK 0000749811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 17,333 shares Expires 2026-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vested and became exercisable, and shall continue to vest and become exercisable, in 36 equal monthly installments beginning on June 17, 2016, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 16:40 UTC |
GEORGIOU GEORGEDirector
|
Exercise / conversionCommon Stock | 20,000 | $4.73 | $94,600.00 |
DisclosureSEC source: 0001567619-18-001186 · doc1.xml · nonDerivative · entry 2 GEORGIOU GEORGE · CIK 0000749811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 16:40 UTC |
GEORGIOU GEORGEDirector
|
Exercise / conversionCommon Stock | 17,333 | $7.28 | $126,184.24 |
DisclosureSEC source: 0001567619-18-001186 · doc1.xml · nonDerivative · entry 1 GEORGIOU GEORGE · CIK 0000749811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2018 Filed Jul 20, 2018 17:26 UTC |
Quinn Anthony G.Director · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $9.36 | $0.00 |
DisclosureSEC source: 0001140361-18-033053 · doc1.xml · derivative · entry 4 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-07-17 F4 · derivative.exercise_date: The stock option vests and becomes exercisable contingent upon achievement of certain regulatory milestones. Read SEC document |
| July 18, 2018 Filed Jul 20, 2018 17:26 UTC |
Quinn Anthony G.Director · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $9.36 | $0.00 |
DisclosureSEC source: 0001140361-18-033053 · doc1.xml · derivative · entry 3 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-07-17 F3 · derivative.exercise_date: The stock option vests and becomes exercisable contingent upon achievement of certain product development milestones. Read SEC document |
| July 18, 2018 Filed Jul 20, 2018 17:26 UTC |
Quinn Anthony G.Director · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $9.36 | $0.00 |
DisclosureSEC source: 0001140361-18-033053 · doc1.xml · derivative · entry 2 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-07-17 F2 · derivative.exercise_date: The stock option vests and becomes exercisable contingent upon achievement of certain stock price milestones. Read SEC document |
| July 18, 2018 Filed Jul 20, 2018 17:26 UTC |
Quinn Anthony G.Director · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $9.36 | $0.00 |
DisclosureSEC source: 0001140361-18-033053 · doc1.xml · derivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-07-17 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on August 18, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| July 13, 2018 Filed Jul 17, 2018 16:27 UTC |
LAWLIS V BRYANDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 36,800 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001140361-18-032716 · doc1.xml · derivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,800 Underlying: Common Stock · 36,800 shares Expires 2028-07-12 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 36 equal monthly installments beginning on August 13, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 09:04 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 14,866 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001140361-18-032462 · doc1.xml · derivative · entry 4 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,534 Underlying: Common Stock · 14,866 shares Expires 2028-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 09:04 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $7.04 | $0.00 |
DisclosureSEC source: 0001140361-18-032462 · doc1.xml · derivative · entry 3 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2027-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 09:04 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionCommon Stock | 14,866 | $6.31 | $93,804.46 |
DisclosureSEC source: 0001140361-18-032462 · doc1.xml · nonDerivative · entry 2 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 09:04 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionCommon Stock | 24,000 | $7.04 | $168,960.00 |
DisclosureSEC source: 0001140361-18-032462 · doc1.xml · nonDerivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 09:05 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,307 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001140361-18-032316 · doc1.xml · derivative · entry 2 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,291 Underlying: Common Stock · 3,307 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vested and became exercisable as to 1/36th of the shares subject to the option on April 3, 2016, and thereafter vests as to 1/36th of the shares each month in equal installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 09:05 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionCommon Stock | 3,307 | $5.46 | $18,056.22 |
DisclosureSEC source: 0001140361-18-032316 · doc1.xml · nonDerivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 18:44 UTC |
GEORGIOU GEORGEDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 18,400 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0001140361-18-027928 · doc1.xml · derivative · entry 1 GEORGIOU GEORGE · CIK 0000749811 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Underlying: Common Stock · 18,400 shares Expires 2028-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 18:47 UTC |
Shanafelt ArmenDirector · 10% owner
|
GrantDirector Stock Option (right to buy) · Derivative | 18,400 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0001140361-18-027931 · doc1.xml · derivative · entry 1 Shanafelt Armen · CIK 0001656151 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Underlying: Common Stock · 18,400 shares Expires 2028-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 22:45 UTC |
Mahatme SandeshDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 18,400 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0001140361-18-027929 · doc1.xml · derivative · entry 1 Mahatme Sandesh · CIK 0001511034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Underlying: Common Stock · 18,400 shares Expires 2028-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 22:43 UTC |
Cox Russell J.Director
|
GrantDirector Stock Option (right to buy) · Derivative | 18,400 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0001140361-18-027927 · doc1.xml · derivative · entry 1 Cox Russell J. · CIK 0001512984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Underlying: Common Stock · 18,400 shares Expires 2028-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 22:42 UTC |
Bruhn Suzanne LouiseDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 18,400 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0001140361-18-027926 · doc1.xml · derivative · entry 1 Bruhn Suzanne Louise · CIK 0001517790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Underlying: Common Stock · 18,400 shares Expires 2028-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| May 11, 2018 Filed May 14, 2018 20:01 UTC |
Novartis Bioventures Ltd10% owner
NOVARTIS AG10% owner
|
SaleCommon Stock | 19,550 | $10.06 | $196,673.00 |
DisclosureSEC source: 0001140361-18-023310 · form4.xml · nonDerivative · entry 1 Novartis Bioventures Ltd · CIK 0001297709 · 10% owner NOVARTIS AG · CIK 0001114448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175,314 F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $10.00 to $10.25. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F2 · ownership.direct: The shares are directly owned by Novartis Bioventures Ltd. Novartis Bioventures Ltd. is a wholly-owned indirect subsidiary of Novartis AG, which is an indirect beneficial owner of the reported securities. Read SEC document |
| May 10, 2018 Filed May 11, 2018 20:28 UTC |
Novartis Bioventures Ltd10% owner
NOVARTIS AG10% owner
|
SaleCommon Stock | 22,725 | $10.13 | $230,204.25 |
DisclosureSEC source: 0001140361-18-023060 · form4.xml · nonDerivative · entry 2 Novartis Bioventures Ltd · CIK 0001297709 · 10% owner NOVARTIS AG · CIK 0001114448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,194,864 F3 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $10.00 to $10.34. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F2 · ownership.direct: The shares are directly owned by Novartis Bioventures Ltd. Novartis Bioventures Ltd. is a wholly-owned indirect subsidiary of Novartis AG, which is an indirect beneficial owner of the reported securities. Read SEC document |
| May 09, 2018 Filed May 11, 2018 20:28 UTC |
Novartis Bioventures Ltd10% owner
NOVARTIS AG10% owner
|
SaleCommon Stock | 51,230 | $10.11 | $517,935.30 |
DisclosureSEC source: 0001140361-18-023060 · form4.xml · nonDerivative · entry 1 Novartis Bioventures Ltd · CIK 0001297709 · 10% owner NOVARTIS AG · CIK 0001114448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,217,589 F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $10.00 to $10.48. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F2 · ownership.direct: The shares are directly owned by Novartis Bioventures Ltd. Novartis Bioventures Ltd. is a wholly-owned indirect subsidiary of Novartis AG, which is an indirect beneficial owner of the reported securities. Read SEC document |
| May 08, 2018 Filed May 9, 2018 20:01 UTC |
Novartis Bioventures Ltd10% owner
NOVARTIS AG10% owner
|
SaleCommon Stock | 26,557 | $10.03 | $266,366.71 |
DisclosureSEC source: 0001140361-18-022477 · form4.xml · nonDerivative · entry 2 Novartis Bioventures Ltd · CIK 0001297709 · 10% owner NOVARTIS AG · CIK 0001114448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,268,819 F3 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $10.00 to $10.12. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F2 · ownership.direct: The shares are directly owned by Novartis Bioventures Ltd. Novartis Bioventures Ltd. is a wholly-owned indirect subsidiary of Novartis AG, which is an indirect beneficial owner of the reported securities. Read SEC document |
| May 07, 2018 Filed May 9, 2018 20:01 UTC |
Novartis Bioventures Ltd10% owner
NOVARTIS AG10% owner
|
SaleCommon Stock | 15,548 | $10.11 | $157,190.28 |
DisclosureSEC source: 0001140361-18-022477 · form4.xml · nonDerivative · entry 1 Novartis Bioventures Ltd · CIK 0001297709 · 10% owner NOVARTIS AG · CIK 0001114448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,295,376 F1 · price: Reflects sales of common stock executed in multiple transactions at prices ranging from $10.00 to $10.33. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. F2 · ownership.direct: The shares are directly owned by Novartis Bioventures Ltd. Novartis Bioventures Ltd. is a wholly-owned indirect subsidiary of Novartis AG, which is an indirect beneficial owner of the reported securities. Read SEC document |
| March 22, 2018 Filed Mar 26, 2018 12:05 UTC |
Magovcevic-Liebisch IvanaDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 36,800 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001140361-18-014889 · doc1.xml · derivative · entry 1 Magovcevic Ivana · CIK 0001279281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,800 Underlying: Common Stock · 36,800 shares Expires 2028-03-21 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 36 equal monthly installments beginning on April 22, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 18:25 UTC |
Wooldridge JamesChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001140361-18-009668 · doc1.xml · derivative · entry 1 Wooldridge James · CIK 0001710641 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-02-19 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 18:22 UTC |
Schuchart AaronChief Business Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001140361-18-009664 · doc1.xml · derivative · entry 1 Schuchart Aaron · CIK 0001709258 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-02-19 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 18:23 UTC |
Quinn Anthony G.Director · Interim CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 178,400 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001140361-18-009665 · doc1.xml · derivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,400 Underlying: Common Stock · 178,400 shares Expires 2028-02-19 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:24 UTC |
York Charles N IIChief Financial Officer and VP
|
GrantEmployee Stock Option (right to buy) · Derivative | 92,100 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001140361-18-009666 · doc1.xml · derivative · entry 1 York Charles N II · CIK 0001655962 · Chief Financial Officer and VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,100 Underlying: Common Stock · 92,100 shares Expires 2028-02-19 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 16:36 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 15,211 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001140361-18-009074 · doc1.xml · derivative · entry 2 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,598 Underlying: Common Stock · 15,211 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vested and became exercisable as to 1/36th of the shares subject to the option on April 3, 2016, and thereafter vests as to 1/36th of the shares each month in equal installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 16:36 UTC |
Quinn Anthony G.Director · Interim CEO
|
Exercise / conversionCommon Stock | 15,211 | $5.46 | $83,052.06 |
DisclosureSEC source: 0001140361-18-009074 · doc1.xml · nonDerivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Dec 10, 2018 17:40 UTC |
Quinn Anthony G.Director · President & CEO
|
PurchaseCommon Stock | 2,000 | $6.02 | $12,040.00 |
DisclosureSEC source: 0001567619-18-007640 · doc1.xml · nonDerivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,793 F1 · shares: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 19:06 UTC |
Quinn Anthony G.Director · Interim CEO
|
PurchaseCommon Stock | 600 | $5.07 | $3,039.00 |
DisclosureSEC source: 0001140361-17-045528 · doc1.xml · nonDerivative · entry 3 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,409 F3 · price: Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $5.01 to $5.10 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 19:06 UTC |
Quinn Anthony G.Director · Interim CEO
|
PurchaseCommon Stock | 2,800 | $4.99 | $13,966.96 |
DisclosureSEC source: 0001140361-17-045528 · doc1.xml · nonDerivative · entry 2 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,809 F2 · price: Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $4.88 to $5.10 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 19:06 UTC |
Quinn Anthony G.Director · Interim CEO
|
PurchaseCommon Stock | 4,888 | $4.92 | $24,072.42 |
DisclosureSEC source: 0001140361-17-045528 · doc1.xml · nonDerivative · entry 1 Quinn Anthony G. · CIK 0001532219 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,009 F1 · price: Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $4.77 to $5.05 per share. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.